Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. LLY
LLY logo

LLY News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

LLY News

Eli Lilly's GLP-1 Drug Sales Surge Remarkably

16h agoYahoo Finance

Alphabet and Eli Lilly: Investment Opportunities for the Next Decade

21m agoFool

Alphabet and Eli Lilly Show Bright Prospects Ahead

23m agoNASDAQ.COM

Eli Lilly's GLP-1 Drug Sales Surge

16h agoFool

Eli Lilly's GLP-1 Drug Sales Surge Amid Competition

16h agoNASDAQ.COM

Investment Opportunities in GLP-1 Drugs in Healthcare

1d agoFool

Eli Lilly Reshapes Weight Loss Market with New Launch

1d agoNASDAQ.COM

Eli Lilly's Innovation Drives Long-Term Growth

1d agoFool

LLY Events

04/16 11:50
Walmart Expands Health Management Services Platform
As more customers seek support for weight management and overall health, Walmart is expanding its Better Care Services platform with new offerings that bring together virtual care, nutrition services and pharmacy access in one experience. Better Care Services connects customers to curated third-party providers alongside pharmacy services, nutrition insights and delivery options. The platform now includes weight management support services for customers on or exploring GLP-1 therapies, complementing the access they already have to medications through Walmart's nearly 4,600 pharmacies nationwide. Walmart is also launching a redesigned GLP-1 digital destination on Walmart.com, helping customers explore related products and services, and find medically reviewed nutrition guidance.
04/16 09:30
Senator Sanders Report Finds Prescription Drug Prices Continue to Rise
A report led by Senator Bernie Sanders found that prescription drug prices have continued to rise despite prior pricing agreements with Presidnet Donald Trump, with some medications seeing significant increases and new drugs launching at very high annual costs, NBC News' Berkeley Lovelace Jr. reports. The findings highlight ongoing challenges in controlling U.S. drug pricing ahead of a Senate hearing on the issue. Publicly traded companies in the space include AstraZeneca (AZN), Bristol Myers (BMY), Eli Lilly (LLY), GSK (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY).

LLY Monitor News

Eli Lilly's Foundayo Receives FDA Approval for Obesity Treatment

Apr 01 2026

Eli Lilly's EBGLYSS Shows Positive Results in Pediatric Eczema Trial

Mar 17 2026

Eli Lilly Launches Zepbound® KwikPen® to Improve Obesity Treatment Access

Mar 05 2026

Eli Lilly's Zepbound KwikPen Receives FDA Approval for Obesity Treatment

Feb 23 2026

Eli Lilly's Strong Q4 2025 Results Amid Market Competition

Feb 05 2026

Eli Lilly Reports Strong Q4 2025 Results and 2026 Guidance

Feb 04 2026

Eli Lilly's $3.5 Billion Investment in Manufacturing Facility

Feb 03 2026

Eli Lilly's $1.12B Deal with Seamless Therapeutics

Jan 28 2026

LLY Earnings Analysis

Eli Lilly Q3 2025 Earnings: Revenue Growth & Strategic Gains- Intellectia AI™
5 months ago
Eli Lilly Q2 2025 Earnings: Record Growth & Future Prospects- Intellectia AI™
8 months ago
Eli Lilly's Triumph in Q4 2024 - Intellectia AI™
1 years ago
Eli Lilly and Company Reports Third Quarter 2024 Financial Results
1 years ago

People Also Watch